Xavier Verhelst

Associate Professor of Hepatology

Ghent University

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Xavier Verhelst is an Associate Professor of Hepatology at Ghent University, Belgium. His research predominantly focuses on metabolic impacts on liver health, liver transplantation, and the diagnostic criteria for various liver conditions. Recent contributions to the field include studies on the complications of metabolic surgery and the effects of maternal obesity on liver diseases.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (20)

Pierre‐Emmanuel Rautou

FRANCE

Xavier Verhelst

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD

The double-edged sword of metabolic and bariatric surgery: extending the biliary limb can trigger bacterial translocation, sepsis, and liver inflammation – an experimental study

Liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient

Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis

Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

Editorial: Recompensation in PBC is good. But is it good enough?

Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis

Systematic review : glycomics as diagnostic markers for hepatocellular carcinoma

Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis

Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection

An unusual cause of portal hypertension

Impact on follow-up strategies in patients with primary sclerosing cholangitis

Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.

Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation

90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial

Intensive lifestyle management improves steatosis and fibrosis in pediatric non-alcoholic fatty liver disease.

Serum Glycomics on Postoperative Day 7 Are Associated With Graft Loss Within 3 Months After Liver Transplantation Regardless of Early Allograft Dysfunction.

Focal eosinophilic infiltration of the liver, benign or malignant?

The neurogliovascular unit in hepatic encephalopathy.

A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.

Diagnostic and prognostic scoring systems for autoimmune hepatitis: a review.

Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1.

Collaborators (20)

Pierre‐Emmanuel Rautou

Annika Bergquist

Anja Geerts

Sander Lefere

Ewa Wunsch

Hans Van Vlierberghe

Martti Färkkilä

ANGELA PUENTE

Lindsey Devisscher

Rafael Bañares

Laure Elkrief

Tobias J. Weismüller

Mathieu Vinken

Cynthia Levy

Christoph Schramm

Andrea De Gottardi

Aldo J. Montano-Loza

Jose Ignacio Fortea

Ruth De Bruyne

Ynto S. de Boer

Make your next move.